METHOTREXATE PHARMACOKINETICS

[11] GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007

[12] HAMILTON WF, 1962, HDB PHYSIOLOGY 2

[13] HENDERSON ES, 1965, CANCER RES, V25, P1018

[14] HEPNER GW, 1969, BRIT J HAEMATOL, V16, P241

[15] HIMMELBLAU DM, 1968, PROCESS ANALYSIS SIM

[16] JOHNS DG, 1968, J NUCL MED, V9, P530

[17] LIEGLER DG, 1969, CLIN PHARMACOL THER, V10, P849

[18] MAPLESON WW, 1963, J APPL PHYSIOL, V18, P197

[19] MCDONALD CJ, 1968, LANCET, V1, P864

[20] SIKOV MR, 1969, GROWTH, V33, P57

[11] GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007

[12] HAMILTON WF, 1962, HDB PHYSIOLOGY 2

[13] HENDERSON ES, 1965, CANCER RES, V25, P1018

[14] HEPNER GW, 1969, BRIT J HAEMATOL, V16, P241

[15] HIMMELBLAU DM, 1968, PROCESS ANALYSIS SIM

[16] JOHNS DG, 1968, J NUCL MED, V9, P530

[17] LIEGLER DG, 1969, CLIN PHARMACOL THER, V10, P849

[18] MAPLESON WW, 1963, J APPL PHYSIOL, V18, P197

[19] MCDONALD CJ, 1968, LANCET, V1, P864

[20] SIKOV MR, 1969, GROWTH, V33, P57